Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2023-07-27 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-23-043597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-27 | 2023-07-25 | TRLV | Thronson Susan | Dir | A - Grant | $0.00 | +11.5K | 20.8K | +124% | $0 |
| D | 2023-07-27 | 2023-07-25 | TRLV | Thronson Susan | Dir | A - Grant | $0.00 | +25.6K | 25.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2023-07-25 | A | A | 11,503 | $0.00 | 20,767 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-25 | A | A | 25,597 | $0.00 | 25,597 | D | $6.52 · 2023-07-25 to 2030-07-24 | 25,597 Subordinate Voting Shares | (F2) All of the options became exercisable upon grant on July 25, 2023. |